|
Volumn 3, Issue 2, 2001, Pages 87-89
|
Internal cardioversion. Is it needed? How best to perform it
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIARRHYTHMIC AGENT;
HEPARIN;
MIDAZOLAM;
WARFARIN;
ANESTHESIST;
ANTICOAGULATION;
ASTHMA;
CARDIOVERSION;
CATHETER;
CATHETER ABLATION;
COST EFFECTIVENESS ANALYSIS;
DEFIBRILLATOR;
DISEASE DURATION;
DRUG SAFETY;
EDITORIAL;
ELECTRIC ACTIVITY;
ELECTRODE;
ELECTROPHYSIOLOGY;
EMPHYSEMA;
ENERGY;
EUROPE;
FOLLOW UP;
FRANCE;
GENERAL ANESTHESIA;
HEART ATRIUM FIBRILLATION;
HEART FAILURE;
HEART LEFT VENTRICLE FUNCTION;
HEART RIGHT ATRIUM;
HEART RIGHT VENTRICLE;
HOSPITAL ADMISSION;
HOSPITALIZATION;
HUMAN;
IMPEDANCE;
INTRACARDIAC THROMBOSIS;
LUNG DISEASE;
LUNG EDEMA;
NONHUMAN;
PRIORITY JOURNAL;
PULMONARY ARTERY;
PULMONARY VEIN;
RANDOMIZATION;
RECURRENT DISEASE;
SEDATION;
SHEEP;
SINUS RHYTHM;
STUNNED HEART MUSCLE;
TECHNIQUE;
TRANSESOPHAGEAL ECHOCARDIOGRAPHY;
TREATMENT INDICATION;
WAVEFORM;
ANIMALS;
ATRIAL FIBRILLATION;
ELECTRIC COUNTERSHOCK;
ELECTRODES;
EQUIPMENT DESIGN;
HEART CATHETERIZATION;
HUMANS;
TREATMENT OUTCOME;
|
EID: 0035044553
PISSN: 10995129
EISSN: None
Source Type: Journal
DOI: 10.1053/eupc.2001.0158 Document Type: Editorial |
Times cited : (2)
|
References (21)
|